Development of quantitative receptor-ligand binding assay for use as a tool to estimate immune responses against Plasmodium vivax Duffy binding protein Region II.
about
Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium VivaxHuman vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies.Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians.Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial
P2860
Development of quantitative receptor-ligand binding assay for use as a tool to estimate immune responses against Plasmodium vivax Duffy binding protein Region II.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Development of quantitative re ...... ffy binding protein Region II.
@en
Development of quantitative re ...... ffy binding protein Region II.
@nl
type
label
Development of quantitative re ...... ffy binding protein Region II.
@en
Development of quantitative re ...... ffy binding protein Region II.
@nl
prefLabel
Development of quantitative re ...... ffy binding protein Region II.
@en
Development of quantitative re ...... ffy binding protein Region II.
@nl
P2860
P1476
Development of quantitative re ...... uffy binding protein Region II
@en
P2093
Ahmad Rushdi Shakri
P2860
P304
P356
10.1080/15321819.2012.659781
P577
2012-01-01T00:00:00Z